After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Verona Pharma Plc ADR is $3.39B. A total of 1.1 million shares were traded on the day, compared to an average of 989.99K shares.
In the most recent transaction, ZACCARDELLI DAVID sold 640,264 shares of VRNA for 5.01 per share on Dec 05 ’24. After the transaction, the President and CEO now owns 14,367,552 company shares. In a previous transaction on Dec 06 ’24, ZACCARDELLI DAVID sold 162,800 shares at 5.01 per share. VRNA shares that President and CEO owns now total 14,204,752.
Among the insiders who sold shares, ZACCARDELLI DAVID disposed of 67,608 shares on Dec 04 ’24 at a per-share price of $5.00. This resulted in the President and CEO holding 15,007,816 shares of VRNA after the transaction. In another insider transaction, Hahn Mark W sold 640,048 shares at $5.01 per share on Dec 05 ’24. Company shares held by the Chief Financial Officer now total 13,477,464.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, VRNA has a high of $40.97 and a low of $11.39.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. VRNA’s latest balance sheet shows that the firm has $148.38M in Cash & Short Term Investments as of fiscal 2021. There were $5.81M in debt and $33.42M in liabilities at the time. Its Book Value Per Share was $1.59, while its Total Shareholder’s Equity was $148.00M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRNA is Buy with a score of 5.00.
